Supernova Invest led a €20m Series A round in SeqOne Genomics.

Supernova Invest, a European multi-stage VC firm, led a €20m Series A round in SeqOne Genomics, a pioneer in AI-driven genomic analysis for personalized medicine, with participation from Elaia, Omnes, and Merieux Equity Partners. This latest investment will be pivotal in SeqOne's mission to establish itself as the European champion in Next-Generation Sequencing (NGS) data analysis and interpretation for clinical diagnostics, with a clear ambition to become the world-leading software in this dynamic field, where the demand for precise and scalable genomic interpretation is accelerating globally. The financing also places SeqOne in a strong financial position, reinforcing its commitment to being a reliable, long-term partner for its customers.